Patients who took a GLP-1 drug fared better than those in a control group at keeping their blood glucose levels in a healthy ...

Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.

In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic ...

Related Massive study looks at benefits, risks of GLP-1 weight-loss drugs GLP-1 medications show promise in slowing ... GLP-1 drug use rose from 0.1% of the population in 2018 to 0.4% in 2022.

For this study, researchers analyzed U.S. federal research data in which people were asked about their GLP-1 prescriptions. Results showed that among people without diabetes, GLP-1 drug use rose ...

GLP-1 drugs like Ozempic help with weight loss, but how do they stack up against bariatric surgery? A new study breaks it ...

Sleeve gastrectomy and gastric bypass were associated with about five-times more weight loss than weekly injections of GLP-1 ...

Overweight patients given an experimental weight loss drug being developed by China's Sciwind Biosciences lost an average of ...

NEW YORK, May 27, 2025 /PRNewswire/ -- Over two percent of adult patients now take a GLP-1 drug to treat overweight ... websites and newsletters. How we use your information depends on the ...

The rising use of glucagon-like peptide-1 (GLP ... of drug that mimics the glucagon-like peptide-1 hormone. It stimulates insulin secretion and reduces appetite, helping to control blood sugar and ...

"This large cohort study represents a reassuring safety signal showing that GLP-1 drugs are not ... links between GLP-1 use and pancreatic cancer. And this just shows, as have other human studies ...